BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
UBS
Citi
Merck
Cipla
McKinsey
QuintilesIMS
Cerilliant
Fuji
Federal Trade Commission

Generated: January 20, 2018

DrugPatentWatch Database Preview

Chlorpheniramine maleate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for chlorpheniramine maleate and what is the scope of chlorpheniramine maleate freedom to operate?

Chlorpheniramine maleate
is the generic ingredient in twenty-four branded drugs marketed by Aurolife Pharma Llc, Glaxosmithkline, Schering Plough, Bel Mar, Elkins Sinn, Watson Labs, Schering, Pharm Assoc, Bayer Healthcare Llc, Avanthi Inc, Alza, Bayer Pharms, Anabolic, Bell Pharma, Impax Labs, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Newtron Pharms, Panray, Pharmavite, Pharmeral, Pioneer Pharms, Purepac Pharm, Pvt Form, Roxane, Sun Pharm Industries, Vitarine, West Ward, Halsey, Lannett, Spriaso Llc, Acella Pharms Llc, Tris Pharma Inc, Cypress Pharm, Bio-pharm Inc, Paddock Llc, Mayne Pharma Inc, Pfizer, Graham Dm, Novartis, Schwarz Pharma, Fisons, and Cent Pharms, and is included in sixty-two NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for chlorpheniramine maleate. Five suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for chlorpheniramine maleate

US Patents and Regulatory Information for chlorpheniramine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pvt Form CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 080786-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West Ward CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 083787-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Tris Pharma Inc HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; hydrocodone bitartrate SOLUTION;ORAL 206438-001 Jan 27, 2015 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs CHLORPHENIRAMINE MALEATE chlorpheniramine maleate INJECTABLE;INJECTION 086095-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 080779-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis TRIAMINIC-12 chlorpheniramine maleate; phenylpropanolamine hydrochloride TABLET, EXTENDED RELEASE;ORAL 018115-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurolife Pharma Llc CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 080961-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Acella Pharms Llc HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; hydrocodone bitartrate SOLUTION;ORAL 206891-001 Jun 9, 2017 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Newtron Pharms CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 086519-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs CHLORPHENIRAMINE MALEATE chlorpheniramine maleate INJECTABLE;INJECTION 083593-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for chlorpheniramine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alza EFIDAC 24 CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET, EXTENDED RELEASE;ORAL 019746-002 Nov 18, 1994 ➤ Subscribe ➤ Subscribe
Alza EFIDAC 24 CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET, EXTENDED RELEASE;ORAL 019746-002 Nov 18, 1994 ➤ Subscribe ➤ Subscribe
Alza EFIDAC 24 CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET, EXTENDED RELEASE;ORAL 019746-002 Nov 18, 1994 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
UBS
Baxter
Novartis
Boehringer Ingelheim
Johnson and Johnson
Colorcon
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot